NCT00129376 - Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

July 31, 2005

Study Completion Date

February 28, 2010

Conditions

Breast Cancer

Interventions

DRUG

Doxorubicin

DRUG

Cyclophosphamide

DRUG

Docetaxel

Trial Locations (6)

Complejo Hospitalario Universitario A Coruña, A Coruña

Fundación Jiménez Díaz, Madrid

Hospital de la Ribera, Alzira

Hospital Universitario Germans Trias i Pujol, Badalona

Corporació Sanitaria Parc Taulí, Sabadell

Hospital General Universitario de Alicante, Alicante